Development of polypodna based dendritic nano-sized DDS
Project/Area Number |
26860021
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Physical pharmacy
|
Research Institution | Setsunan University |
Principal Investigator |
Mohri Kohta 摂南大学, 薬学部, 助教 (30723697)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 核酸 / ナノ粒子 / DDS / CpGモチーフ / DNA assembly / dendritic structure / CpG motif / macrophage / innate immunity |
Outline of Final Research Achievements |
To increase the therapeutic potency of immunostimulatory CpG DNA, we tried to develop polypod-like structured DNA, or polypodna based dendritic nano-sized DDS. We succeeded in constructing dendritic-like DNA (DL-DNA) by connecting polypodnas through their adhesive terminal ends, but not ligating with enzymatic reaction. Furthermore, we found that DL-DNA was efficiently taken up by immune cells, which dramatically increased the cytokine release by CpG DNA. Thus, we have shown that the DL-DNA developed by this approach, can be an useful nano-sized DDS for increasing the potency of nucleic acid drugs.
|
Report
(4 results)
Research Products
(12 results)
-
[Journal Article] Optimal Arrangement of Four Short DNA Strands for Delivery of Immunostimulatory Nucleic Acids to Immune Cells2015
Author(s)
Shozo Ohtsuki, Noriyuki Matsuzaki, Kohta Mohri, Masayuki Endo, Tomoko Emura, Kumi Hidaka, Hiroshi Sugiyama, Yuki Takahashi, Kenichi Ishiyama, Norimitsu Kadowaki, Yoshinobu Takakura, Makiya Nishikawa.
-
Journal Title
Nucleic Acid Therapeutics
Volume: 25
Issue: 5
Pages: 245-253
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-